Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-130228
Filing Date
2022-12-27
Accepted
2022-12-27 17:17:32
Documents
2
Period of Report
2022-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2233473d4_6k.htm 6-K 17997
2 EXHIBIT 1.1 tm2233473d4_ex1-1.htm EX-1.1 1044112
  Complete submission text file 0001104659-22-130228.txt   1063085
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 221491059
SIC: 2836 Biological Products, (No Diagnostic Substances)